Showing results (211-220 of 276) with videos related to

Sort By:
Pageof 28
International Journal of Cancer|December 11, 1996
Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populationsB Nonnenmacher, S Kruger Kjaer, E I Svare, et al.
Virology|July 26, 2006
Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particlesLigia A Pinto, Raphael Viscidi, Clayton D Harro, et al.
The Lancet. Oncology|June 16, 2022
Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine TrialJaimie Z Shing, Shangying Hu, Rolando Herrero, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human PrimatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1997
Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesionsH D Strickler, M H Schiffman, C Eklund, et al.
NPJ Vaccines|September 28, 2023
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primatesAlexandra Fowler, Koen K A Van Rompay, Maureen Sampson, et al.
Virology|May 12, 2005
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2Diana V Pastrana, Ratish Gambhira, Christopher B Buck, et al.
Journal of the National Cancer Institute|September 18, 1997
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancerJ Dillner, M Lehtinen, T Björge, et al.
Vaccine|April 28, 2005
HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodLigia A Pinto, Philip E Castle, Richard B Roden, et al.
The Journal of Infectious Diseases|July 11, 2003
Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particlesLigia A Pinto, Jessica Edwards, Philip E Castle, et al.
Pageof 28